课题基金 / 基金详情

Endobiotics glucuronidation: a novel therapeutic avenue for metabolic and endocrine diseases

Endobiotics glucuronidation: a novel therapeutic avenue for metabolic and endocrine diseases
内生素葡萄糖醛酸化:代谢和内分泌疾病的新治疗途径
批准号:
172371
负责人:
Barbier Olivier
金额:
$21.86万
依托单位:
依托单位国家:
加拿大
项目类别:
Salary Programs
财政年份:
2008
资助国家:
加拿大
项目状态:
已结题
起止时间:
2008-09-01 至 2013-09-01

项目摘要

项目成果

Barbier Olivier的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Glucuronidation is an enzymatic reaction very well studied for the role its plays in drug elimination. However, this reaction also affects a wide variety of endogenous substance. The aim of our research program is to determine whether controlling the elim
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The UGT to GUS equilibrium as novel target for the treatment of cholestatic autoimmune liver diseases.
  • 批准号:
    435621
  • 项目类别:
    Operating Grants
  • 资助金额:
    $69.94万
  • 财政年份:
    2020
  • 负责人:
    Barbier Olivier
  • 依托单位:
Therapeutic potential of obeticholic acid for the treatment of advanced prostate cancer
  • 批准号:
    342907
  • 项目类别:
    Operating Grants
  • 资助金额:
    $37.59万
  • 财政年份:
    2016
  • 负责人:
    Barbier Olivier
  • 依托单位:
Antioxidant effects of n3-polyunsaturated fatty acids in the vasculature.
  • 批准号:
    239962
  • 项目类别:
    Operating Grants
  • 资助金额:
    $36.24万
  • 财政年份:
    2011
  • 负责人:
    Barbier Olivier
  • 依托单位:
FXR: a promising target for prostate cancer treatment
  • 批准号:
    180504
  • 项目类别:
    Operating Grants
  • 资助金额:
    $49.88万
  • 财政年份:
    2009
  • 负责人:
    Barbier Olivier
  • 依托单位:
海外基金